ClinicalTrials.gg
CompletedNCT03450200Updated May 10, 2019

Effectiveness of Exercises in Patient With Diabetic Peripheral Neuropathy

An interventional study of exercises for diabetic peripheral neuropathy and Health education for diabetic foot care in Diabetic Peripheral Neuropathy, sponsored by Okayama University. Completed at 1 site in Japan. Open to participants aged 25 Years and older. Per ClinicalTrials.gov, last updated 2019-05-10.

Sponsored by Okayama University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Jun 2017, registered Feb 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
121
Allocation
Randomized
Ages
25 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 10 studies in Motor Activity with a site in Japan — 2 open to participants now, 2 under way, none of them phase 3. Motor Activity · Japan.

Started
2017
the only one that year
No phase
6 of 10
2 open now
Registered
5th of 10
by date
Lead sponsor
1 of 10
Okayama University

Among the 10 studies in Motor Activity with a site in Japan, this one is the only one that started in 2017, is one of 6 with no phase, and was the 5th registered.

Motor Activity

9,798 studies on the registry are indexed under Motor Activity; 1,910 are open to participants now.

Browse Motor Activity studies →

Open to participants now

2 of the 10 studies in Motor Activity with a site in Japan are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →

Who these studies take

Of the 1,201 Motor Activity studies recruiting now, 517 (43%) set no upper age limit and 535 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.

This study: 25 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Motor Activity with a site in Japan, or all of them as a file.
02

Study summary

Diabetic Peripheral Neuropathy (DPN) is the common complication seen in the diabetic patients. Moreover, it will lead to another complication as disabilities and difficulties in activities of daily living (ADL). Most of the intervention for diabetes and diabetic neuropathic patients are mostly focusing on the prevention of foot ulcer. Diabetic foot care can prevent only for diabetes-related foot ulcer and foot amputation. It cannot be reduced DPN and cannot be improved the activities of daily living of the patient with DPN. Moreover, there is the restriction of weight-bearing exercise on the recommendation of exercises for the patients with DPN. Therefore, exercise program which may be suitable for all the patients with DPN was introduced in this study to improve ADL and decrease the neuropathic symptoms in the diabetic patients.

Compliance with exercise or intervention is not only critical to get adherence but also for the long-term use of its. Easy to do exercise in the short duration which can able to do on their own in their home promote their compliance and adherence to the exercises. In this study, the effectiveness of exercises in the patients with diabetic peripheral neuropathy was examined to fulfill the requirement of exercises which is simple and can be done in a short time. The objective of the study is to examine the effectiveness of exercise in the patients with diabetic peripheral neuropathy.

03

Conditions studied

  • Diabetic Peripheral Neuropathy

Browse trials for

Keywords

  • Diabetic Peripheral Neuropathy, Exercises
04

Who can participate

Ages eligible
25 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • The patients receiving diabetic care at the out-patient-department of designated hospitals, able to contact via the telephone, presence of signs and symptoms of DPN, agreed to involve in the study (), and aged over 25 years

Exclusion criteria

Exclusion Criteria:

  • The persons who are suffering from DPN other than diabetes, severe illness of diabetic patients, diabetes with other comorbidities, amputation of hands and feet from any reasons, mental illness and alcoholism
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
121 participants (actual)

Study arms

  • Experimental
    Exercises Group

    three times daily exercises of hands and fingers exercises and foot exercises which last for 10 minutes in eight weeks, and health education about diabetic foot care

    Other: exercises for diabetic peripheral neuropathy · Other: Health education for diabetic foot care

  • Other
    Control Group

    health education about diabetic foot care

    Other: Health education for diabetic foot care

Interventions

  • Otherexercises for diabetic peripheral neuropathy

    Hands, fingers, and foot exercises for diabetic peripheral neuropathy to improve activities of daily living, and decreases the signs and symptoms of DPN

  • OtherHealth education for diabetic foot care

    Health education for daily diabetic foot care to prevent diabetic foot ulcer was provided.

06

What researchers measure

Primary outcomes

  1. Change in Activities of daily living (ADLs) after intervention, at follow-up

    ADLs were measured by using Patient Neurotoxicity Questionnaire (PNQ).

    Time frame: eight weeks after intervention, eight weeks follow-up

  2. Change in signs of DPN after intervention, at follow-up

    DPN was assessed by using monofilament (SMW), Touch-TestTM Sensory Evaluator 5 Pieces Hand Kit of North Coast Medical Inc.

    Time frame: eight weeks after intervention, eight weeks follow-up

  3. Change in signs of DPN after intervention, at follow-up

    DPN was assessed by tuning fork vibration test.

    Time frame: eight weeks after intervention, eight weeks follow-up

Secondary outcomes

  1. Change in strength of hand grip

    Hand grip was measured in kilograms by using TTM original Dynamometer 100 kg.

    Time frame: eight weeks after intervention, eight weeks follow-up

  2. Change in strength of pinch force

    Key (lateral pinch) was measured by the gold standard B\&L Engineering® Pinch Gauge 0-30 lb. in 1.0 lb.

    Time frame: eight weeks after intervention, eight weeks follow-up

  3. Change in walking speed

    Timed Up and Go (TUG) test was to measure the duration for walking in seconds.

    Time frame: eight weeks after intervention, eight weeks follow-up

07

Study locations

1 site
  • Okayama University
    Okayama, 7008558, Japan
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2017 to primary completion in Oct 2017, 3 months.

Of 5,147 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's 3 months is below that.

Counting every sponsor, half of 5,207 studies reached it within 17 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 19, 2018
First posted
Mar 1, 2018
StartActual
Jun 17, 2017
Primary completionActual
Oct 16, 2017
CompletionActual
Oct 16, 2017
Last update
May 10, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 10, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03450200
Lead sponsor
Okayama University
Responsible party
Mi Mi Thet Mon Win (Graduate Student, Okayama University) — Principal investigator
First posted
Mar 1, 2018
Start date
Jun 17, 2017
Primary completion
Oct 16, 2017
Completion
Oct 16, 2017
Last update
May 10, 2019

Study contacts

Mi Mi Thet Mon Win, PhD student
principal investigator · Graduate School of Health Sciences, Okayama University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion